Enhanced activation of key oncogenic signalling pathways (PI3K/AKT, RAS/MAPK and MYC) upstream of ribosome biogenesis constitutes yet another hallmark of HGSC,9 and we hypothesise that inhibiting ribosome biogenesis can provide an effective cancer therapeutic option.10 Indeed, We have now proven encouraging responses Using the ribosomal RNA gene (rDNA) transcription inhibitor https://glycerolphenylbutyrate77654.sharebyblog.com/31604683/the-fact-about-yoda-1-that-no-one-is-suggesting